Skip to content
Head to head

LivaNova vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: LIVN · ABT

Updated 6 minutes ago

1-year performance, rebased to 100

LIVN +69.1%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories pays the highest dividend yield; Abbott Laboratories earns the most per share.
LIVNABT
Snapshot
SectorMedical DevicesMedical Devices
Last price90.73103.00
Change today-1.46%-0.84%
1-year return+69.8%-15.4%
Market cap$5.00B$178.39B
52-week range56.44 – 99.3880.89 – 126.70
Valuation
P/E (TTM)26.0038.29
P/E percentile, own 5-yr range75th99th
P/B3.643.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)-4.453.72
Net profit (TTM)$-245.14M$6.44B
Revenue (TTM)$1.51B$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+9.9%+14.5%
Gross margin67.8%56.9%
Operating margin10.7%13.8%
Net margin13.0%9.7%
Free cash flow (TTM)$129.02M$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership117.4%81.2%
Insider activity (12mo)29 buy / 20 sell36 buy / 12 sell
Short interest (% of float)11.5%1.1%
Analyst consensus100% buy (6)93% buy / 7% hold (15)
Analyst price target$111 (+23%)$122 (+18%)
StockVane view
StockVane Quant RatingC (93)D (20)
Company
Employees3,300115,000
Founded19871900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.